Six-hour ECG recordings were performed every four months during follow-up periods (4-48 months) in 915 patients less than 66 years of age who survived the hospital phase of myocardial infarction. One hundred ninety-nine episodes of ventricular tachycardia (VT) were identified in 66 patients. Most patients (74%) had only one episode of VT. In 47% of the patients, the longest run of VT consisted of three ventricular premature beats in a row. A double set of control patients (N = 132) was assembled by matching each VT patient according to sex, admission date and VT recording date. The VT and control patients were similar in most clinical characteristics. However, VT patients had more severe cardiac disease (P < 0.05) and more evidence of ventricular irritability (P < 0.01) than their From the Heart Research Follow-up Program matched controls. The mortality rates in the VT and control groups were 16% (11/66) and 8% (11/132), respectively (P < 0.11). The risk of VT patients dying was 2.35 (95% confidence interval 0.82 to 6.77) times that of patients without VT. Life-table analysis of the survival of VT and control patients revealed a 48-month VT survival of 75% compared to 87% in the control group. Among those who died, the age, sex, cause of death, suddenness of death and mechanism of death were similar in the VT and control patients. Within the VT group, those who died had more severe underlying heart disease than the survivors. The occurrence of VT in the posthospital phase of myocardial infarction, while associated with a lower survival rate, does not indicate as much danger as generally assumed.
FOR MANY YEARS VENTRICULAR TACHY-CARDIA (VT) was considered an uncommon arrhythmia in ambulatory patients. With the advent of continuous monitoring, VT has been recognized with increasing frequency.1' 2 The need for understanding the clinical setting and prognostic implications of VT has grown as its recognition has increased. Ventricular tachycardia occurs in a variety of conditions, and when it is recorded in subjects who otherwise lack objective evidence of heart disease, the arrhythmia has limited implications.2 In contrast, VT in association with acute myocardial infarction has been considered a lifethreatening arrhythmia. 3 A variety of studies have reported on the occurrence of VT in patients surviving the acute period of myocardial infarction, but few follow-up results have been done.5'1-Recently, Winkle et al. 12 pointed out that studies relating VT to cardiac death in postinfarction patients have had too few subjects to reach any statistical conclusions. They suggested that VT in the nonacute setting may not always be malignant. Nevertheless, a consensus exists that VT appearing in the late hospital or posthospital phase of myocardial infarction is a harbinger of sudden death. '3-15 In this investigation, the clinical features and mortality of 66 patients who survived the acute hospital phase of myocardial infarction and were found subsequently to have at least one run of VT are presented and compared to 132 control patients without VT.
Methods

Coronary Population
The coronary population consisted of Monroe County patients less than 66 years of age who entered coronary care units in two of Rochester's community hospitals between January 1, 1973 and September 30, 1976 , who had either a definite or probable acute myocardial infarction and survived the hospitalization. Patients were considered to have definite myocardial infarction if any two of the following were present: typical coronary type chest pain, serial acute myocardial enzyme changes, or evolving Q wave abnormality with acute ST and T wave changes on ECG. Probable myocardial infarction ("acute coronary insufficiency") patients had typical coronary type chest pain with minor enzyme changes and/or acute ST and T wave changes on ECG. Patients and their private physicians were required to give informed consent before entering the study. A total of 915 patients who survived the hospital phase of their definite or probable myocardial infarction were enrolled in this prospective research protocol during the aforementioned time interval.
Data Acquisition
The patients were interviewed during the last week of hospitalization by a nurse investigator and the hospital chart reviewed. The patients' medical history prior to entry and their clinical course during the CCU and subsequent hospitalization were recorded on prospectively developed computer format forms. Numerous clinical variables were considered for the purposes of this study including: 1) demographic data; 2) smoking history 3) New York Heart Association (NYHA) functional status prior to entry; 4) cardiovascular co-morbidity with ordinal classification of severity of diabetes, hypertension, and other cardiovascular conditions; 5) severity of the acute coronary event in terms of hemodynamic and arrhythmic complications; 6) 12-lead ECG prior to discharge coded according to the Minnesota classification;16 and 7) a six-hour Holter-type ECG tape recording. The Holter recording was applied for six hours during ordinary daytime ambulatory activity in the last few days before discharge. The ECG tape recordings were analyzed manually using Avionic rapid (60:1) scan technique for 1) basic rhythm; 2) maximum, minimum, and average heart rate; 3) maximum ST-segment shift; 4) atrial arrhythmias; and 5) ventricular arrhythmias. All identified ventricular arrhythmias were classified and quantitated according to the following system: 1) VPBsunifocal/multifocal; 2) bigeminy; 3) pairs; 4) idioventricular rhythm; and 5) ventricular tachycardia. Rate measurements of runs of VPBs were made in real time. Ventricular tachycardia was defined as a run of three or more VPBs at a peak rate greater than or equal to 100 beats/min. Follow-up Patients were followed at intervals of four months. Data collected at follow-up visits included medications, a 12-lead resting ECG and a six-hour daytime ambulatory Holtertype recording which was analyzed as indicated above.
Information on terminal events occurring up to January 15, 1977 was obtained from the victim's spouse and private physician as well as from hospital charts of those who died in-hospital according to the procedure and definitions previously described by this group."7 Study Population (VT Group) From the basic population of 915 patients, 66 were identified as having VT on one or more of their six-hour Holter recordings.
Control Groups
The patients with VT were matched with 132 patients without VT from the same coronary population. Every VT patient was characterized by sex, date of entry (hospital admission date), and date that VT was first recorded. Each VT patient was then matched with a control patient of the same sex whose entry date and corresponding non-VT recording date during follow-up most closely approximated the entry and VT recording dates of the patient with VT. The resulting set of 66 patients made up Control Group No. 1. Corresponding dates fell within ± 15 days of each other. A second match was performed in the same fashion excluding patients in Control Group No. 1. Corresponding dates between patients with VT and members of Control Group No. 2 fell within ± 30 days of each other. The decision to match according to sex was made after a preliminary match suggested that sex might be a confounding factor (see below).
Statistical Analysis
The clinical characteristics of the VT and control groups were compared, and differences were evaluated using the Z statistic. The differences are reported in terms of the absolute value of Z with P values inferred from standard tables. Two-tailed Fisher's exact test and Students's t-test were used to test the significance of the differences between the characteristics of the terminal events of the VT and the control groups. Two-tailed Yates corrected Chi square test was used to test the significance of the difference between the characteristics of the VT patients who died and survived during follow-up. When information regarding a variable was unavailable for a particular patient, that patient was excluded from the analysis of that variable.
The differences in mortality between the patients with VT and the control patients were analyzed by the modified McNemar's test with correction for continuity for the two matched control groups described by Miettinen.'8 A twotailed test was used to determine the significance of the mortality difference between the VT and control groups. The estimated relative risk ratio and 95% confidence interval (Yates corrected) were computed by the method of Miettinen. '9 Actuarial analysis of survival in VT and control patients was performed by the life-table method of Cutler and Ederer.'0 The sequential intake of patients resulted in many 
Results
Characteristics of Patients with Ventricular Tachycardia
Over 5,000 six-hour ambulatory ECG recordings from 915 post-myocardial infarction patients revealed 199 episodes of VT in 66 patients. Forty-nine patients (74%) had only one episode of VT, 16 patients had between 2-12 episodes, and one patient had 74 runs of VT ( fig. 1 ). The longest run of VT consisted of three beats for 31 patients ( fig. 2 ). No patient had a run greater than 20 beats. For each of the 66 patients with VT, only the first recorded episode of VT was utilized in the analysis. Figure 3 indicates the distribution of the number of beats in the first episode of VT of each patient. The average peak rate of VT was 152 ± 24 beats/min (mean ± standard deviation) with a range of 100 to 246 beats/min ( fig. 4 ). The mean heart rate before the run of VT was 87 ± 19 beats/min (fig. 5). All but two patients had prematurity indices (RR'/QT) at the onset of VT greater than 1.0 (97%) ( fig. 6 ). The mean prematurity index for the first beat of VT was 1.49 ± 0.37. Figure 7 illustrates the results of a life-table type of analysis ("event-table") applied to the cumulative percent-50 74% age occurrence of VT during the four-year follow-up time after myocardial infarction. This type of analysis takes into consideration the changing number of patients at risk for developing VT as patients die or are followed for different periods of time. The predischarge occurrence of VT was 1.1%. The rate at which VT was identified for the first time, estimated by the slope of the graph, was somewhat higher in the first nine months (0.5% per month) than in the 12 to 36 month period (0.2% per month), and then increased between months 36 to 46 (0.6% per month). The cumulative occurrence of VT after 45 months was 15.5%. 
5'
Comparison of VT Patients with Control Patients
In the preliminary selection of a control group, patients were not matched for sex. It was discovered that 9% of the VT patients were women compared to 23% of the preliminary control group. The probability that this could occur by chance was less than 10% (P < 0.1). Furthermore, three of the six women with VT eventually died. It was decided that the control groups should also be matched for sex to enhance the homogeneity of the VT and control groups.
Once the two control groups matched with the VT group were assembled, the characteristics of the two control groups (No. 1 The VT patients and the combined control group were compared with respect to status at entry, severity of myocardial infarction, and arrhythmias occurring while in the coronary care unit (table 1). The VT group had a significantly (P < 0.01) higher fraction of members with one or more ventricular premature beats (VPBs) identified in the coronary care unit. VT patients had proportionately more (P < 0.05) members with NYHA Class IV angina, NYHA Class IV symptoms in those patients with a previous myocardial infarction, pulmonary congestion, higher Peel indices and VPB pairing in the coronary care unit. VT in the coronary care unit was equally distributed among VT and control patients. 10 20 MONTHS AFTER Ml 30 40 45 FIGURE 7. Actuarial analysis ofthe cumulative occurrence ofventricular tachycardia (VT) after myocardial infarction (MI) for 66 patients. Standard errors are shown for the cumulative occurrence at 6, 12, 24 and 45 months.
The characteristics of the resting ECGs and the continuous six-hour ECGs taken before discharge from hospital and at the time VT was first discovered (corresponding time for control patients) were compared (table 2). A significantly greater proportion (P < 0.01) of VT patients had fastest supraventricular heart rates _ 120 beats/min in the six-hour ECG taken at the time of VT. The VT group had significantly more members with any VPBs, VPB frequency 5 per 1,000 QRS complexes, and multiform VPBs on the six-hour ECG in both predischarge and time of VT recordings. A significantly higher percentage of VT patients had bigeminy on their six-hour recording at the time of VT. Proportionately fewer (P < 0.05) patients with VT had IS-T-J depression 0.5 mm or more and ST segment horizontal or downward sloping in any of leads I, II, aV., aVF, V1-6; or, ST segment downward sloping and segment or T wave nadir at least 0.5 mm below PR baseline in any of leads I, II, aV, L V2-6. **Z score and P value not appropriate. heart rates less than 60 beats/min than control patients. In the week before VT was recorded, the proportions of VT and control patients who smoked, or used digitalis, propranolol or tranquilizers were similar (table 3) . A greater fraction (P < 0.05) of the VT group used diuretics and significantly (P < 0.01) more VT patients than controls were using procainamide or quinidine at this time.
Mortality
Eleven of 66 patients with VT died (16.6%) compared to II of 132 control patients (8.3%). The significance of this difference was tested by the modified McNemar's test for two matched control groups."8 The difference in mortality between the VT and the control patients was not statistically significant (P = 0.1 1). The estimated relative risk of VT patients dying was 2.35 (95% confidence interval 0.82 to 6.77) times that of a patient without VT.
A graph using life-table analysis of the survival of VT and control patients over time after VT (or equivalent non-VT recording) was first noted is presented in figure 8 . The cumulative survival of the VT patients 12 months after the arrhythmia was discovered was 85% compared to 93% for Although the VT group had a lower survival rate over time than did the control group, the difference was not significant. The clinical characteristics of the VT and control patients who died are presented in table 4. No significant differences existed between the two mortality groups in sex, age or characteristics of the terminal event. The mechanism of death as previously defined'7 was similar in the two groups 0 10 20 30 40 50 MONTHS AFTER VT. with a suspected primary arrhythmia (documented asystole or fibrillation in the absence of shock or pulmonary edema, or sudden K 12 hoursl death without immediate cause) in 73% of the VT and 64% of the control patients who died. During the week before demise, 91% of the VT patients and 45% of the control patients were on digitalis (P < 0.01).
Other drug usage and smoking status were similar in the two groups.
A comparison of selected clinical characteristics in the 11 VT patients who died and the 55 VT survivors is presented in table 5. The variables are listed in decreasing order of significance from the largest Chi square value down to values > 2.71 (P < 0.10). The most significant univariate discriminator was advanced NYHA functional classification in patients with prior myocardial infarction (P < 0.005). The Peel Index,22 a multivariate discriminator which includes age, sex, prior history, shock, failure, ECG Q waves and rhythm status, also provided excellent identification (P < 0.01). ECG Q waves, female sex, and the occurrence of VT and early cycle VPBs on the predischarge Holter ECG tape recording were of borderline significance (0.05 . P _ 0.10). These findings suggest that VT mortality is related in part to the severity of the underlying heart disease as well as to other clinical and electrical parameters.
Discussion
The first part of this investigation was confined to the description of the electrocardiographic features of the first episodes of VT which occurred during the follow-up of 915 patients who survived the hospital phase of myocardial infarction. A recent paper by Winkle et al.12 presented data on the electrocardiographic details of VT. Although they drew their data from 23 patients with a variety of cardiac diseases (8 with coronary artery disease, 5 with mitral valve prolapse, 5 with idiopathic hypertrophic subaortic stenosis, 2 with cardiomyopathies and 2 apparently normal patients), their results were generally similar to the data presented here. In the present study, 55% of the first episodes of VT consisted of 3 beats, a finding comparable to that of Winkle et al. who observed 48% of all episodes of VT consisted of 3 beats. Winkle et al. found an average VT rate of 148 ± 26 beats/min, an average preceding heart rate of 83 ± 17 beats/min, and an average prematurity index of 1.31 ± 0.28. Our results are remarkably similar.
Although data from the two studies are not strictly comparable, the similarities suggest that VT found in postmyocardial infarction is similar to VT found in other nonacute forms of cardiac disease. Thus, VT in the ambulatory patient appears to consist of infrequent, self-limited episodes, often no longer than 3 beats in duration. Our results support another finding of Winkle et al., namely that most episodes of VT are not initiated by the R-on-T phenomenon. Only 3% of our patients had prematurity indices less than 1.00.
Ventricular tachycardia was identified in 1% of the predischarge recordings, a figure lower than is generally reported.5' 14, 23 Longer recording times and populations unrestricted as to age in previous studies probably account for this discrepancy. The cumulative occurrence of VT after 45 months of 15% reflects the long follow-up period and the large total number of ECG recording hours.
The second part of the investigation compared the clinical characteristics of the 66 VT patients with 132 controls. The VT group had more cardiac symptoms prior to entry and more severe infarctions. VPB pairing and the occurrence of any VPBs were observed more frequently in the CCU in the VT patients than in the controls. However, less than half of the patients who eventually developed VT were noted to have VPBs in the coronary care unit. It is interesting to note that almost 25% of both groups had VT in the coronary care unit. It is evident that coronary care unit arrhythmias bear little relation to future ventricular arrhythmias, and this finding has been noted by others.5' 14 15, 24 Comparison of the six-hour ECG recordings demonstrated marked differences between patients with and without VT. In the six-hour ECGs recorded before hospital discharge and at the time VT was first noted, VT patients demonstrated more ventricular irritability. In addition, the patients with VT had a significantly higher percentage with fastest heart rates greater than or equal to 120 beats/min. Wenger et al.24 found that heart rates greater than 85 beats/min were associated with VPBs and VT in the late hospital phase of myocardial infarction. Winkle et al.'2 found that most episodes of VT occurred during normal heart rates in patients with a variety of cardiac disorders. The more rapid heart rates among VT patients in the present study may be a reflection of impaired cardiac function. This is supported by the fact that the VT group had more members with severe cardiac disease, e.g., NYHA Class IV angina, interstitial or pulmonary edema and higher Peel indices. Schulze et all' also found an association between complex ventricular arrhythmias and decreased left ventricular ejection fraction or left ventricular dyskinesia.
The final part of this investigation consisted of evaluating the characteristics of the baseline variables and the terminal events of those who died and comparing the mortality rates in the VT and control patients. Among the VT and control patients who died there were no statistically significant differences with respect to sex, age, cause of death, suddenness of death or mechanism of death. Most patients in both groups died in less than 24 hours, and most died of a suspected primary arrhythmia. It is evident that the characteristics of the terminal events between the VT and the control groups were similar. It is interesting that digitalis usage was greater in the VT than in the non-VT patients who died. Although the increased usage of digitalis in the VT patients who died may be a therapeutic covariate of more severe underlying myocardial disease, it is also possible that digitalis usage in patients with VT may lower the threshold for lethal cardiac arrhythmias. The causal role of digitalis in its association with mortality in the VT group cannot be determined from this study.
By the end of the follow-up period, the mortality rate in the VT group was 16.6% compared to 8.3% in the combined control group. This difference was not statistically signifi-cant (P = 0.11). The estimated risk ratio was 2.35:1 (95% confidence interval 0.82 to 6.77). In other words, a patient found to have VT in the posthospital phase of myocardial infarction has an estimated risk of dying which is somewhat over twice that of a similar patient without VT. The large 95% confidence interval indicates that this risk ratio is of borderline significance. The question arises whether the modestly increased mortality among patients with VT is related to the arrhythmia or to the severity of the intrinsic cardiac disease. The findings presented in table 5 indicate that within the VT group cardiac mortality was associated with the more severe heart disease.
Other investigators have observed that VT in the late or posthospital phase of myocardial infarction is an ominous finding.13-"5 As presented in table 6, 39 to 50% of patients with VT in this period die suddenly, but the numbers were very small. The results of the present study indicate that patients found to have VT in the late hospital or posthospital period of myocardial infarction have a small excess mortality over similar patients without VT.
Actuarial analysis of the VT and control groups showed a rapid initial decline in survival during the first 12 months after VT was detected, followed by a more gradual decline from 12 to 48 months. The survival of VT patients was 85% at 12 months and 75% at the end of 48 months while the survival of the control group at 12 and 48 months was 93% and 87% respectively. The large standard errors shown in figure  8 indicate the extent to which the two curves overlap.
A semantic problem exists over what constitutes VT. Two ventricular ectopic beats in a row are categorized as pairs. Marriott and Myerburg in Hurst's textbook The Heart25 define VT as three or more ectopic ventricular beats occurring at a rate equivalent to 100 beats per minute. This definition was utilized in the present study and in the recent report of Winkle et al.'2 However, Lown4 and other physicians use the term "salvo" for a three beat pattern, and they classify longer sequences of ventricular ectopic beats as VT. In this study, 55% of the patients had a three beats run of VT, and 73% had VT consisting of three or four beats. There were not enough patients in the present study to ascertain whether longer runs of VT have more ominous prognostic significance than the shorter patterns. Also, the clinical relationship between these relatively short bursts of VT and sustained VT is unclear, but the recent electrophysiologic studies suggest a common mechanism.26 For these reasons the authors recommend that VT remain defined as a pattern of three or more ventricular ectopic beats.
